The deal will advance global research in key areas such as drug discovery, development, toxicology, and personalized medicine
BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, announced an exclusive commercial agreement with Handok Biotech Co. LTD., which will allow Handok to offer researchers in South Korea access to a wider range of high-quality, innovative products. The strategic alliance provides unparalleled opportunities for researchers, ultimately, elevating life science research in Asia.
Health Technology Insights: England’s NICE recommends FILSPARI as a treatment option for IgA nephropathy
The Agreement’s Regional Impact
With this agreement, Handok Biotech will exclusively represent BioIVT’s comprehensive portfolio of biofluids, tissues, cell products, media, and subcellular fractions/enzymes in South Korea. Access to this diverse range of biological materials is essential to drive drug discovery, development, toxicology, and personalized medicine research.
Health Technology Insights: Hexaware Accelerates Delivery Solutions with a New Office in Chicago
“We are excited to collaborate with Handok Biotech to further propel life sciences research in East Asia,” said Dimas Neto, Director, Global Channel Partnerships at BioIVT. “Together, we remain dedicated to advancing scientific discoveries that have the potential to transform healthcare and improve patient outcomes worldwide.”
“By combining Handok Biotech’s long-standing experience and strong presence in the region, and BioIVT’s industry-leading products, we’re eager to create unparalleled opportunities for researchers to access high-quality, reliable solutions,” said Mun-Chul Lee, CEO at Handok Biotech. “This relationship will provide faster lead times and competitive pricing, while ensuring ongoing technical support and customer service, further enhancing the overall research experience.”
Health Technology Insights: AANA Applauds Introduction of Nursing Workforce Program Reauthorization
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – businesswire
